• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

ECHSX:US

11.73 USD 0.16 1.38%

As of 19:59:59 ET on 04/16/2014.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (ECHSX)

Year To Date: +1.03% 3-Month: -4.17% 3-Year: +17.38% 52-Week Range: 9.17 - 13.19
1-Month: -7.05% 1-Year: +24.03% 5-Year: +17.26% Beta vs SPX: 0.91

Mutual Fund Chart for ECHSX

No chart data available.
  • ECHSX:US 11.73
  • 1M
  • 1Y
Interactive ECHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ECHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 01-05-1998 Telephone: 1-617-482-8260
Managers: SAMUEL D ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for ECHSX

NAV (on 2014-04-16) 11.73
Assets (M) (on 2014-03-31) 1,369.06
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for ECHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Irreg
Last Dividend Net (on 2013-12-17) 0.18
Dividend Yield (ttm) 11.52

Fees & Expenses for ECHSX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.91
Redemption Fee 1.00
12b1 Fee 1.00
Expense Ratio 2.14

Top Fund Holdings for ECHSX

Filing Date: 12/31/2013
Name Position Value % of Total
Roche Holding AG 317,000 88,799,994 7.011%
Gilead Sciences Inc 920,000 69,138,000 5.459%
HCA Holdings Inc 1,130,000 53,912,300 4.256%
Regeneron Pharmaceuticals Inc 188,000 51,745,120 4.085%
Incyte Corp Ltd 1,000,000 50,630,000 3.997%
Mylan Inc/PA 1,070,000 46,438,000 3.666%
Amgen Inc 392,000 44,750,720 3.533%
Ono Pharmaceutical Co Ltd 497,700 43,626,133 3.444%
Bristol-Myers Squibb Co 788,000 41,882,200 3.307%
Biogen Idec Inc 149,600 41,850,600 3.304%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil